Posts Tagged 'lawsuit against Risperdal'

J&J Said to Pay $2.2 Billion to End Risperdal Sales Probe

Johnson & Johnson has agreed to pay as much as $2.2 billion to settle U.S. probes of the marketing of its Risperdal antipsychotic drug and other medications, two people familiar with the negotiations said. The settlement, which might be announced this week, will include a misdemeanor plea and criminal penalty of as much as $600 million. The accord also would resolve civil claims that J&J paid kickbacks to Omnicare Inc., a company that dispenses drugs at nursing homes, the people said.

Read more about the Risperdal settlements…

J&J ordered to pay $1.1 billion in Risperdal lawsuit

Johnson & Johnson has been ordered to pay $1.1 billion concerning claims by the state of Arkansas that the company hid the health risks of the antipsychotic drug Risperdal from doctors and patients. The verdict is the drug company’s third consecutive loss in Risperdal lawsuits in state courts regarding the marketing of the drug.

Click here to read more…

J&J to Agree to $1B Accord in Risperdal Probe

Johnson & Johnson will pay more than $1 billion to the U.S. and most states to resolve a civil investigation into marketing of the antipsychotic Risperdal, according to people familiar with the matter. The U.S. government has been investigating Risperdal sales practices since 2004, including allegations the company marketed the drug for unapproved uses, J&J has said in Securities and Exchange Commission filings.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 437 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.